← All trials
NCT07240649
Phase 4Interventional
Studies of FDA-approved drugs to delineate additional information including the drug's risks, benefits, and optimal use.
View on ClinicalTrials.gov ↗Timeline
- Start date
- Dec 31, 2025
- Primary completion
- Dec 31, 2035
- Completion date
- Dec 31, 2035
- First posted
- Nov 21, 2025
- Last posted
- Nov 24, 2025
- Enrollment
- 100
- Arms / groups
- 1 / —
- Source
- AACT · ctgov ingestion
Sponsors
- Dartmouth UniversityLead sponsor
- Dartmouth UniversityCollaborator
- Dartmouth UniversitySponsor investigator
Drugs studied
Indications studied
- Dermal Fillers
- Invasive Fungal Infections
- COVID-19
- Calciphylaxis
- Cartilage Diseases
- Colitis, Ulcerative
- Crohn Disease
- Cystitis
- Pressure Ulcer
- Enterocolitis, Pseudomembranous
- Epidermolysis Bullosa
- Femur
- Fissure in Ano
- Frostbite
- Graft vs Host Disease
- Craniocerebral Trauma
- Hypospadias
- Intestinal Diseases
- Ligaments
- Multiple Sclerosis
- Osteonecrosis
- Pain
- Pterygium
- Raynaud Disease
- Rectovaginal Fistula
- Retinal Vein Occlusion
- Tinnitus
- Retinal Artery Occlusion
- Prosthesis-Related Infections
- Pyoderma Gangrenosum
- Optic Neuropathy, Ischemic
- Myositis, Inclusion Body
- Pouchitis
- Trauma, Nervous System
CDEK-curated fields only — the ClinicalTrials.gov results mirror (baseline measures, adverse events, participant flow) is a separate, currently-dormant pipeline; see MIGRATION_PLAN.md.